Thursday, October 15, 2026

Is The Market Turning The Page?

CoreWeave’s debt and equity price action is framed as a wake-up call for investors amid a broader market discussion.

CRWV $34B

WHAT ARE WE DOING? “Contrarians At The Gate” Oct 15 53 clicks

Oct 15 MOD $9.2B

Modine Deep Dive

CV's Substack 19 clicks

Oct 15 APP $88B

AppLovin Deep Dive

Speedwell Research 27 clicks

From X

@BarbarianCap Sep 23

Barbarian Capital on X

$CROX is the footwear for historic moments https://t.co/BWIcDcD92J

@junkbondinvest Sep 23 1 click

junkbondinvestor on X

Update on Loparex, the loan Blue Owl marked from 88 to 5 cents in just 8 months. The restructuring is now set. $OWL's entire ~$160mm 2L gets wiped out for a small piece of equity. Monarch and General Atlantic take control after buying the 1L at distressed prices earlier this year. Looks like the 5 cent mark in June was close to right. The question was always why it was 88 six months earlier...

@BlueDuckCap Sep 23 1 click

BDC on X

Security was a breeze at Sofi thanks to $evlv https://t.co/J0TVDC7F8Q

@ACapitalLP Sep 23

A Capital on X

This non-circumvent is very good for $FSLR which is now < $200… https://t.co/Tc3GXdZRLk

@KEDM_COM Sep 23

KEDM.com on X

Visteon $VC announced a $800m buyback (~27% of the market cap) through 2029. With sluggish growth in recent years but solid FCF, cash has been building, and VC has picked up the buying. Things might become interesting again operationally as well. VC is past its toughest 2026 comps and set to inflect on growth (solid wins across 2‑wheelers, commercial vehicles, Toyota, and Asian OEMs). This could mean a return to hsd% organic growth next year, with margins returning to 13%+. Roughly 6x EV/EBITDA.

@ACapitalLP Sep 23

A Capital on X

The $MGM bid was fugazzi. Now we buy? https://t.co/Zi2T462m8v

@Mike10947310 Sep 23 2 clicks

Mike on X

$ESP - solid earnings. Numbers were record high, but main negative is book-to-bill sub 1. However, that's expected as funding will flow in '27. One interesting thing - they added language about positive revenue growth into '27. Normally they haven't provided any sort of guidance.

@John_Hempton Sep 23

John_Hempton on X

@StanG42548339 @420yooper69AMC I appreciate it. By putting all that money into $AMC you allowed $AMC to issue more shares. It used that to repay bonds owned by hedge funds and bought at a discount. Hedge funds made money. You lost. Thanks for playing.

Problems at Dream Finders Homes (DFH)

Dream Finders Homes’ controlling owner borrowed against DFH stock before the homebuilder agreed to finance an acquisition with costly…

DFH $764M

Hunterbrook Oct 15 14 clicks

Park Aerospace: The Q2'27 Sell-Off Misreads a Sole-Source Defense Supplier

Park Aerospace’s 11% Q2’27 sell-off overlooks sole-source PAC-3 rocket-motor materials and A320neo engine composites, with missile capacity…

PKE $571M

Monte Independent Investment Research Oct 15 12 clicks

uniQure: The Market Graded The Wrong Exam

UniQure's Huntington's gene therapy faces an FDA accelerated-approval decision around November 1 after three-year data met both agency…

QURE $1.5B

Bhavneesh Sharma Oct 15 16 clicks

[scuttleslops] MRVL, APP, AMZN, Chips

Marvell is positioning networking, optical connectivity and server-management chips as AI data centers link GPUs, custom accelerators and…

MRVL $208B

scuttleblurb Oct 15 12 clicks

AeroVironment: The Value Is There, Growth Will Force The Market To Notice

AeroVironment's $465M LOCUST laser award and earnings beat support its 2027 growth outlook despite government budget uncertainty.

AVAV $6.2B

Melissa Tucker Oct 15 8 clicks

Constellation: Stars Aligning?

Constellation Brands trades near $127 at roughly 11x next-twelve-month EV/EBIT, with recent business results offsetting concerns over…

STZ $22B

TSOH Investment Research Oct 15 28 clicks

Breaking: The Offshore Monopoly Is Legal Now!

Transocean’s Valaris merger clears regulators, creating a 68-rig offshore driller controlling four in 10 global drillships.

RIG $6.2BVAL $5.8B

Cannibal Stocks Oct 15 44 clicks

October 2026 Random Ramblings

October 2026 market commentary covers SOLS’s cancelled merger, a hypothetical Starbucks-Chipotle deal, Russell 2000 weakness and AI…

SOLS $9.7BSBUX $109B

Yet Another Value Podcast Oct 14 87 clicks

Everyone wants to defend CoreWeave but who really knows

CoreWeave faces fresh skepticism as another AI trade selloff collides with bullish defenses of the company.

CRWV $34B

The Technology Letter Oct 14 6 clicks

A Conversation With Ari Emanuel About Entertainment and AI

Ari Emanuel discusses AI’s impact on Hollywood, live events, social networks and the future of advertising.

TKO $33B

Stratechery by Ben Thompson – On the business, strategy, and impact of technology. Oct 14 8 clicks

BLND · long

Blend Labs INC

Blend Labs (BLND) is presented as a long investment idea, with prior VIC writeups cited for business background.

BLND $217M

Value Investors Club Jul 17 2 clicks

Private Equity Prints Multibaggers With This Pattern. No One is Talking About It.

Shenandoah Telecommunications’ Glo Fiber buildout ends this year, and private infrastructure investors’ repeated fiber deals frame a…

SHEN $556M

Phynvesting Oct 14 21 clicks

RTX Q3 Preview: Two Growth Engines Make This Aerospace And Defense Leader A 'Buy'

RTX’s $289 billion backlog, including $119 billion in defense, supports growth from defense contracts and commercial aerospace aftermarket…

RTX $247B

Blake Winiecki Oct 14 5 clicks

Coherent | Management Call

COHR $52B

P Equity Research Oct 14 19 clicks

Morgan Stanley Direct Lending: Discount Is Attractive, But Credit Has Not Stabilized; Hold

Morgan Stanley Direct Lending trades at a 32% NAV discount as non-accruals reach 2.9%, NII and NAV decline, and dividend coverage falls to…

MSDL $1.5B

Rubicon Associates Oct 14 1 click

Deep Dive: Applied Materials ($AMAT)

Applied Materials leads wafer-fab deposition and ranks third in etch, positioning it for tougher 3D chip manufacturing as investors weigh a…

AMAT $329B

Rebound Capital Oct 14 31 clicks

First Tracks Biotherapeutics: Teva Validated The Pathway, ANB033 May Own The Receptor

First Tracks Biotherapeutics’ ANB033 posted stronger Phase 1b celiac efficacy than Teva’s IL-15 inhibitor, with $168 million funding…

TRAX $1.3BTEVA $48B

Equity Eagle Oct 14 8 clicks

Research Roundup Vol. LVI

Howmet Aerospace is framed as a beneficiary of turbine and aircraft-engine demand, while J.B.

HWM $88BJBHT $22B

Monte Independent Investment Research Oct 14 15 clicks

Lennar: The Misstep Is Temporary, the Operating Machine Is Not

Lennar cut build times to 116 days and adopted an asset-light land model, while gross margin fell to 15.8% from 27.5% as land costs rose.

LEN $18B

Latticework by MOI Global Oct 14 16 clicks

Lennar, Part One: The Story

Lennar grew from a Miami builder into one of America’s two largest homebuilders, controlling land largely through options and land banks…

LEN $18B

Latticework by MOI Global Oct 14 15 clicks

Thursday, October 15, 2026

Barbarian Capital on X

junkbondinvestor on X

BDC on X

A Capital on X

KEDM.com on X

A Capital on X

Mike on X

John_Hempton on X

Investor Letters

Publications we follow

Newsletters 108

YouTube 4

Blogs 17

Seeking Alpha 52 of 241

X accounts we follow

Investor letters we follow

Sectors